Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANDLE study of cannabidiol for difficult-to-control epilepsy in children
RBR-27xy86rPhase 4Recruiting
- Sponsor
- IMIP
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in epilepsy comparing Cannabidiol add-on with Placebo add-on (2 arms). Started Aug 2025; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
epilepsy
Beyond the preview
Go deeper on RBR-27xy86r.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-27xy86r.